Emiel Rutgers

The MINDACT trial: The first prospective clinical validation of a genomic tool

Fatima Cardoso, E. Rutgers, F. Cardoso, 2007, Molecular oncology.

A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples

E. Rutgers, J. Carroll, W. Zwart, 2013, BMC Genomics.

On the feasibility of MRI-guided navigation to demarcate breast cancer for breast-conserving surgery.

Tanja Alderliesten, Marie-Jeanne Vrancken Peeters, Kenneth Gilhuijs, 2010, Medical physics.

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

Marc Buyse, Stella Mook, Jan Bogaerts, 2006, Nature Clinical Practice Oncology.

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Mike Clarke, Yasuo Ohashi, Michael Gnant, 2018, The Lancet. Oncology.